Target intelligence / Profile preview

novel transcript, antisense to NFIC

Molecular classification: Other, Putative non-coding RNA, Antisense transcript

Overview

novel transcript, antisense to NFIC" (ENSG00000305183) refers to an uncharacterized non-coding RNA transcript transcribed on the strand opposite to the nuclear factor I-C (NFIC) gene. It does not correspond to a canonical protein-coding gene or therapeutic target. Antisense transcripts may regulate the expression of the sense gene (such as NFIC) by mechanisms like RNA interference or chromatin remodeling, but specific function, disease role, or therapeutic potential for this transcript has not been established in the medical literature.

Beyond the preview

Go deeper on novel transcript, antisense to NFIC.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on novel transcript, antisense to NFIC.

Explore the full profile